Harmony Biosciences Holdings HRMY
NASDAQ HRMY
$39.64 +0.07 (+0.18%)
At close: Oct 2, 2026 · 4:00 PM EDT

Harmony Biosciences Holdings (HRMY) Non Operating Interest Expenses (2023 - 2026)

Updated

Harmony Biosciences Holdings (HRMY) posted Non Operating Interest Expenses of $3.07 million for Q2 2026, down 15.8% from $3.65 million a year earlier and down 5.1% from the prior quarter.

Analysis

Harmony Biosciences Holdings (HRMY) Non Operating Interest Expenses (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Interest Expenses at Harmony Biosciences Holdings was $13.47 million, down 16.0% year-over-year; for FY2025, it was $14.65 million, down 16.3% from FY2024.

  • Annual Non Operating Interest Expenses shows a four-year compound annual growth rate of -11.8% (FY2021 to FY2025).
  • In prior years, Harmony Biosciences Holdings' Non Operating Interest Expenses was $17.5 million in FY2024 (-26.4%), $23.76 million in FY2023 (+26.4%), $18.8 million in FY2022 (-22.3%) and $24.19 million in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Non Operating Interest Expenses in data going back to Q1 2023.
  • On a year-over-year basis, Non Operating Interest Expenses has declined in each of the last ten quarters, with an average decline of 18.4% over the last eight quarters.
  • The year-over-year decline in Non Operating Interest Expenses has ranged between 12.2% (Q4 2024) and 38.0% (Q3 2024) over the last five years.
  • According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $3.23 million (Q1 2026), $3.55 million (Q4 2025) and $3.62 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 281.00 Mn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -435.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 247.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Harmony Biosciences Holdings 2.30 Bn -456.79 Mn 198.08 Mn 3.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.07 Mn
Mar 31, 2026 3.23 Mn
Dec 31, 2025 3.55 Mn
Sep 30, 2025 3.62 Mn
Jun 30, 2025 3.65 Mn
Mar 31, 2025 3.84 Mn
Dec 31, 2024 4.21 Mn
Sep 30, 2024 4.35 Mn
Jun 30, 2024 4.40 Mn
Mar 31, 2024 4.54 Mn
Dec 31, 2023 4.80 Mn
Sep 30, 2023 7.01 Mn
Jun 30, 2023 6.22 Mn
Mar 31, 2023 5.73 Mn
API Access

Harmony Biosciences Holdings Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=HRMY&period=max&api_key=YOUR_API_KEY